Substance abuse and covid-19

Tiffany Morgan, Project Manager at Siyan Clinical Research, Interview Dr. Anish Shah, CEO at Siyan Clinical Research.

The COVID-19 pandemic has us all reeling, and a lot of people are facing unexpected challenges. Unfortunately, people in recovery from substance use disorders are disproportionately affected, and those who rely on opioid replacement therapy (ORT) to manage opioid addiction will face additional risks and challenges as society learns how to adapt to the pandemic.